Markus Krohn

1.9k total citations
40 papers, 1.3k citations indexed

About

Markus Krohn is a scholar working on Physiology, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Markus Krohn has authored 40 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Physiology, 20 papers in Oncology and 11 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Markus Krohn's work include Alzheimer's disease research and treatments (26 papers), Drug Transport and Resistance Mechanisms (20 papers) and Pharmacological Effects and Toxicity Studies (9 papers). Markus Krohn is often cited by papers focused on Alzheimer's disease research and treatments (26 papers), Drug Transport and Resistance Mechanisms (20 papers) and Pharmacological Effects and Toxicity Studies (9 papers). Markus Krohn collaborates with scholars based in Germany, Norway and Latvia. Markus Krohn's co-authors include Jens Pahnke, Lary C. Walker, Toni Schumacher, Oliver Langer, Kristin Paarmann, Katja Scheffler, Jacqueline Hofrichter, Cathleen Lange, Thomas Brüning and Jan Stenzel and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Brain.

In The Last Decade

Markus Krohn

37 papers receiving 1.3k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Markus Krohn 615 503 330 248 176 40 1.3k
Jelena Popović 355 0.6× 159 0.3× 474 1.4× 120 0.5× 67 0.4× 45 1.2k
Chun‐Ling Dai 890 1.4× 157 0.3× 741 2.2× 452 1.8× 60 0.3× 51 1.9k
Yui Yamamoto 236 0.4× 146 0.3× 860 2.6× 261 1.1× 49 0.3× 56 1.7k
Je‐Seong Won 560 0.9× 131 0.3× 821 2.5× 230 0.9× 46 0.3× 58 1.6k
Michael S. Dobbie 152 0.2× 187 0.4× 441 1.3× 207 0.8× 76 0.4× 22 1.1k
Naoya Matsunaga 396 0.6× 204 0.4× 439 1.3× 36 0.1× 72 0.4× 80 1.5k
Marni E. Harris‐White 834 1.4× 279 0.6× 658 2.0× 350 1.4× 21 0.1× 34 2.1k
Gizem Dönmez 712 1.2× 125 0.2× 879 2.7× 137 0.6× 29 0.2× 43 2.1k
Daniel José Barbosa 152 0.2× 147 0.3× 538 1.6× 85 0.3× 55 0.3× 48 1.3k
Varsha Shukla 299 0.5× 132 0.3× 418 1.3× 125 0.5× 28 0.2× 31 1.1k

Countries citing papers authored by Markus Krohn

Since Specialization
Citations

This map shows the geographic impact of Markus Krohn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Krohn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Krohn more than expected).

Fields of papers citing papers by Markus Krohn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Krohn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Krohn. The network helps show where Markus Krohn may publish in the future.

Co-authorship network of co-authors of Markus Krohn

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Krohn. A scholar is included among the top collaborators of Markus Krohn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Krohn. Markus Krohn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sundaram, Sivaraj Mohana, Helge Müller‐Fielitz, Meri De Angelis, et al.. (2022). Gene therapy targeting the blood–brain barrier improves neurological symptoms in a model of genetic MCT8 deficiency. Brain. 145(12). 4264–4274. 20 indexed citations
3.
Möhle, Luisa, et al.. (2020). Using a qPCR device to screen for modulators of ABC transporter activity: A step-by-step protocol. Journal of Pharmacological and Toxicological Methods. 104. 106882–106882.
4.
Bascuñana, Pablo, Mirjam Brackhan, Markus Krohn, et al.. (2020). Detection and Prediction of Mild Cognitive Impairment in Alzheimer’s Disease Mice. Journal of Alzheimer s Disease. 77(3). 1209–1221. 5 indexed citations
5.
Krohn, Markus, et al.. (2020). Early Cognitive Training Rescues Remote Spatial Memory but Reduces Cognitive Flexibility in Alzheimer’s Disease Mice. Journal of Alzheimer s Disease. 75(4). 1301–1317. 11 indexed citations
6.
Krohn, Markus, Severin Mairinger, Thomas Wanek, et al.. (2019). Generation and Characterization of an Abcc1 Humanized Mouse Model (hABCC1) with Knockout Capability. Molecular Pharmacology. 96(2). 138–147. 9 indexed citations
7.
Mairinger, Severin, Markus Krohn, Thomas Wanek, et al.. (2018). Influence of Multidrug Resistance-Associated Proteins on the Excretion of the ABCC1 Imaging Probe 6-Bromo-7-[11C]Methylpurine in Mice. Molecular Imaging and Biology. 21(2). 306–316. 17 indexed citations
8.
Paarmann, Kristin, Markus Krohn, Luisa Möhle, et al.. (2018). French maritime pine bark treatment decelerates plaque development and improves spatial memory in Alzheimer's disease mice. Phytomedicine. 57. 39–48. 19 indexed citations
9.
Steffen, Johannes, Markus Krohn, Thomas Brüning, et al.. (2017). Expression of endogenous mouse APP modulates β-amyloid deposition in hAPP-transgenic mice. Acta Neuropathologica Communications. 5(1). 49–49. 22 indexed citations
10.
Brüning, Thomas, Petra Sántha, Henrik Biverstål, et al.. (2017). Improved method for cannula fixation for long-term intracerebral brain infusion. Journal of Neuroscience Methods. 290. 145–150. 9 indexed citations
11.
Hofrichter, Jacqueline, et al.. (2016). Sideritis spp. Extracts Enhance Memory and Learning in Alzheimer’s β-Amyloidosis Mouse Models and Aged C57Bl/6 Mice. Journal of Alzheimer s Disease. 53(3). 967–980. 42 indexed citations
12.
Krohn, Markus, Yosef Avchalumov, Toni Schumacher, et al.. (2015). Accumulation of murine amyloid-β mimics early Alzheimer’s disease. Brain. 138(8). 2370–2382. 37 indexed citations
13.
Pahnke, Jens, Kristin Paarmann, Markus Krohn, et al.. (2014). Cerebral ABC Transporter-common Mechanisms May Modulate Neurodegenerative Diseases and Depression in Elderly Subjects. Archives of Medical Research. 45(8). 738–743. 28 indexed citations
14.
Bernstein, Hans‐Gert, Henrik Dobrowolny, Kurt Trübner, et al.. (2014). Vascular and extravascular distribution of the ATP-binding cassette transporters ABCB1 and ABCC1 in aged human brain and pituitary. Mechanisms of Ageing and Development. 141-142. 12–21. 40 indexed citations
15.
Hofrichter, Jacqueline, Markus Krohn, Toni Schumacher, et al.. (2013). Reduced Alzheimer’s Disease Pathology by St. John’s Wort Treatment is Independent of Hyperforin and Facilitated by ABCC1 and Microglia Activation in Mice. Current Alzheimer Research. 10(10). 1057–1069. 69 indexed citations
16.
Schumacher, Toni, Markus Krohn, Jacqueline Hofrichter, et al.. (2012). ABC Transporters B1, C1 and G2 Differentially Regulate Neuroregeneration in Mice. PLoS ONE. 7(4). e35613–e35613. 40 indexed citations
17.
Krohn, Markus, Cathleen Lange, Jacqueline Hofrichter, et al.. (2011). Cerebral amyloid-β proteostasis is regulated by the membrane transport protein ABCC1 in mice. Journal of Clinical Investigation. 121(10). 3924–3931. 149 indexed citations
19.
Pahnke, Jens, Markus Krohn, & Katja Scheffler. (2009). Die Funktion der Blut-Hirn-Schranke für die Pathogenese der Alzheimer-Demenz – Implikationen für immunologische Therapien zur Plaqueauflösung. Fortschritte der Neurologie · Psychiatrie. 77(S 01). S21–S24. 2 indexed citations
20.
Pahnke, Jens, Lary C. Walker, Katja Scheffler, & Markus Krohn. (2009). Alzheimer's disease and blood–brain barrier function—Why have anti-β-amyloid therapies failed to prevent dementia progression?. Neuroscience & Biobehavioral Reviews. 33(7). 1099–1108. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026